Elizabeth Holmes makes her case to the jury in fraud trial

U.S. District Judge Edward Davila failed to explain why he met with lawyers on both sides of the case behind closed doors while a masked – and confused – audience sat in a crowded courtroom.

Holmes’ final testimony came after her lawyers she called to the booth in the final hour of the trial on Friday, the most dramatic moment in a high-profile trial that began in early September.

The expectation for Holmes to return to the booth on Monday drew a large crowd outside the San Jose, California courthouse where the trial is taking place, with the first person lining up around 1 a.m. PT. The 35 or so people who walked into the small courtroom on Monday included one of Holmes’ biggest slides – former Wall Street Journal reporter John Carreyrou, who a. wrote Series of explosive articles from October 2015, which triggered the collapse of Theranos and the criminal trial that followed.

Answering friendly questions from one of her lawyers gives Holmes a chance to influence the jury who will decide her fate. Holmes, a former billionaire now 37, could face up to 20 years in prison if convicted.

After Holmes was asked by her lawyer to explain some blood test terms, Holmes looked directly at the jury, who sat a few yards to her right, and delved into the subject as if she were a teacher addressing her students turns.

After Holmes took off the mask she had worn while sitting during the trial, she also smiled occasionally as she talked about the study. She also tried to make eye contact with the 14 jurors, including two deputies, as they walked out during the morning break and later at the end of the day.

The studies, conducted with several large pharmaceutical companies from 2008 to 2010, showed that the third generation of a Theranos device, known as an Edison, produced mostly encouraging results that led Holmes to believe that she and the company were on the Road to success were.

“The results were excellent,” said a report. Another concluded that the “results were accurate”.

Another exchange between Holmes and her attorney Kevin Downey underscored the expressive tone of Monday’s testimony. When asked by Downey, Holmes stated that she defined success as something that “has successfully achieved the goal of a program”.

The positive reports and Holmes ‘testimony seemed primarily to be aimed at providing a glimpse into Holmes’ state of mind, to shed some light on why it eventually became so exuberant of the Theranos technology it promised, after hundreds of possible diseases and others Health conditions scan for problems with just a few drops of blood taken with the prick of a finger.

But in 2015, Theranos’ own laboratory manager concluded that the company’s technology was failing in ways that led to misleading results that could potentially endanger patients. Theranos ran the tests on traditional blood testing machines while continuing to raise hundreds of millions of dollars from billionaires and less experienced investors.

Other evidence presented in the study showed that in 2013 Holmes released misleading information about an alleged partnership with Pfizer and other pharmaceutical companies that was helping Theranos raise funds.

After spending only about three hours on the stand, it is expected that Holmes’ testimony will eventually penetrate more intriguing territory.

Before the trial began, Holmes’ attorneys filed documents indicating that she intends to attribute the wrongdoing that occurred at Theranos to her former lover and the company’s former chief operating officer, Sunny Balwani. These documents state that Balwani, who faces separate criminal proceedings next year, manipulated Holmes through “abuse of intimate partners”. Balwani’s attorney has blown these allegations as unfounded.

The Holmes testimony continues Tuesday morning and is expected to last into next week.

Leave a Comment